Insider · CIK 0001952723
Anna U Loengard
Files at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). First filing Aug 14, 2025, latest Aug 14, 2025.
Anna U Loengard files SEC Form 4 as director at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). Since Aug 14, 2025, Anna U Loengard has reported 1 open-market buy worth $69k and 0 open-market sells worth $0, the latest filed on Aug 14, 2025.
A track record needs three past buys with six months of prices behind them; Anna U Loengard has 0, so none is measured yet.
The newest scored trade: bought $69k of CLOV on Aug 13, 2025, filed Aug 14, 2025, scored 49 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLOV: CLOVER HEALTH INVESTMENTS, CORP. /DE
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | CLOVER HEALTH INVESTMENTS, CORP. /DE | $69k 26,500 shares | +170% | +20% from low-46% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | AGrant or award Class A Common Stock | +79,365 | $0.00 | $0 | 527,456 | Jan 8, 2026 |
| Aug 13, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | POpen-market purchase Class A Common Stockindirect: By Son IRA | +12,000 | $2.60 | $31k | 27,600 | Aug 14, 2025 |
| Aug 13, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | POpen-market purchase Class A Common Stockindirect: By Daughter IRA | +14,500 | $2.59 | $38k | 29,610 | Aug 14, 2025 |
| Jan 6, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | AGrant or award Class A Common Stock | +60,975 | $0.00 | $0 | 599,816 | Jan 8, 2025 |
Questions about Anna U Loengard
Answered from the filings on this page, as of the latest one.
Is Anna U Loengard buying or selling?
Not in the last 12 months. Anna U Loengard's latest open-market trade on SEC Form 4 was bought $69k of CLOV on Aug 13, 2025.
How did Anna U Loengard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anna U Loengard has 0.
Where does Anna U Loengard file Form 4?
Anna U Loengard has filed Form 4 at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.